Discovery of Novel Anti-Fibrotic Targets in an In Vitro Human Surrogate System of Nonalcoholic Steatohepatitis (NASH)

Time: 11:45 am
day: Day 1 - Stream A - Morning


  • Highlighting a novel in vitro cell culture system to explore phenotypic changes in stellate cells
  • Evaluating fibrotic biomarkers suitable for in vitro applications
  • Using RNAseq and bioinformatics for identifying and validating new therapeutic targets for reversing liver fibrosis